Great Ormond Street Hospital and the Institute of Child health
London, WC1N 1EH, United Kingdom
Completed
NCT Number: NCT00231517
Randomised Double Blind Placebo Controlled Cross Over Design of the Efficacy of Topical Morphine for Inflammatory Pain in Children With Epidermolysis Bullosa
Randomised Double blind placebo controlled cross over design study of the efficacy of morphine for inflammatory pain in children with Epidermolysis Bullosa
Completed
Looking for future studies?
Notify MeKey information
Conditions
Age range
4 year–18 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- children under 18 years epidermolysis wounds requiring dressing changes
Treatment and study plan
topical opiod
Drugmorphine sulphate in intrasite gel
DrugSponsors and collaborators
Lead sponsor
Institute of Child Health
Other
Registry information
Important dates
- First posted
- Oct 4, 2005
- Registry last updated
- Oct 12, 2006
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.